Biotech firm Virax Holdings' shares have jumped 40 per cent after announcing it's set to take over US government funded clinical trials of a drug to treat terminal cancers.

Biotech firm Virax Holdings' shares have jumped 40 per cent after announcing it's set to take over US government funded clinical trials of a drug to treat terminal cancers.